Analog of 1,25-dihydroxy vitamin D3
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

1,24-dihydroxy Vitamin D3 (hydrate)

Item No. 12079

Technical Information
Formal Name
4-methylene-5Z-[2E-[(3aS)-octahydro-1R-[4R-hydroxy-1R,5-dimethylhexyl]-7aR-methyl-4H-inden-4-ylidene]ethylidene]-1R,3S-cyclohexanediol, monohydrate
CAS Number
93129-94-3
Synonyms
  • Bonalfa
  • Curatoderm
  • 1α,24(R)-Dihydroxycholecalciferol
  • PRI 2191
  • Tacalcitol
  • TV 02
Molecular Formula
C27H44O3 • H2O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMSO: 20 mg/mlEthanol: 20 mg/mlEthanol:PBS (pH 7.2) (1:3): 0.30 mg/ml
λmax
212, 264 nm
SMILES
C[C@@]12[C@](CC[C@]2([H])[C@H](C)CC[C@@H](O)C(C)C)([H])/C(CCC1)=C/C=C3C[C@@H](O)C[C@H](O)C/3=C.O
InChi Code
InChI=1S/C27H44O3.H2O/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)19(21)4;/h9-10,17-18,22-26,28-30H,4,6-8,11-16H2,1-3,5H3;1H2/b20-9+,21-10-;/t18-,22-,23-,24+,25-,26+,27-;/m1./s1
InChi Key
UCLYOJXQGOXQKJ-XXBHHXRKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    1,24-dihydroxy Vitamin D3 is an analog of 1,25-dihydroxy vitamin D3 which, when used in a 4 μg/g ointment, safely and effectively suppresses psoriasis.1 It also is effective at increasing the time interval between phototherapy cycles when ultraviolet light is used for psoriasis.2 1,24-dihydroxy Vitamin D3 inhibits the growth of both normal and psoriatic human keratinocytes (IC50 ~ 10 nM) via the vitamin D receptor.3 It also suppresses the production of RANTES and IL-8 by human dermal fibroblasts and reduces cutaneous lymphocyte-associated antigen on CD4+ T cells, impairing migration and skin infiltration.4,5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Leone, G., and Pacifico, A. Profile of clinical efficacy and safety of topical tacalcitol. Acta Biomed. 76(1), 13-19 (2005).

    2. Prignano, F., Buggiani, G., and Lotti, T. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients. Acta Biomed. 80, 51-56 (2009).

    3. Matsumoto, K., Hashimoto, K., Kiyoki, M., et alEffect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. J. Dermatol. 17(2), 97-103 (1990).

    4. Fukuoka, M., Ogino, Y., Sato, H., et alRegulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol). Br. J. Pharmacol. 124(7), 1433-1438 (1998).

    5. Yamanaka, K.I., Kakeda, M., Kitagawa, H., et al1,24-Dihydroxyvitamin D3 (tacalcitol) prevents skin T-cell infiltration. Br. J. Dermatol. 162(6), 1206-1215 (2010).